Bee-io Honey Ltd.
ORCT
OTC PK
| Weiss Ratings | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.00 | |||
| Price History | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | 0.00% | |||
| 2-Year Total Return | 0.00% | |||
| 3-Year Total Return | 0.00% | |||
| 5-Year Total Return | 0.00% | |||
| 52-Week High % Change | -16.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 06, 2025 | |||
| 52-Week High Price (Date) | Mar 06, 2025 | |||
| Valuation | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.51M | |||
| Enterprise Value | 8.37M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.83 | |||
| Earnings Per Share Growth | -58.85% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.54 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -10.07 | |||
| Enterprise Value/EBIT | -8.53 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.91M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 972 8 6131198 | |||
| Address | -- | |||
| Website | bee-io.com | |||
| Country | Israel | |||
| Year Founded | 1990 | |||
| Profitability | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -32.80% | |||
| Return on Equity | -- | |||
| Income Statement | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -1.20M | |||
| EBIT (TTM) | -1.42M | |||
| Net Income (TTM) | -1.54M | |||
| Net Income Avl. to Common (TTM) | -1.54M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 41.98% | |||
| EPS Diluted (TTM) | -0.83 | |||
| EPS Diluted Growth (Q YOY) | 43.57% | |||
| Balance Sheet | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 101.20K | |||
| Cash Per Share (Q) | $0.05 | |||
| Total Current Assets (Q) | 140.20K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -7.40K | |||
| Current Ratio (Q) | 0.158 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 2.26M | |||
| Total Current Liabilities (Q) | 888.20K | |||
| Total Debt (Q) | 1.89M | |||
| Total Liabilities (Q) | 2.27M | |||
| Total Common Equity (Q) | -7.40K | |||
| Cash Flow | ORCT - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 82.70K | |||
| Cash from Financing (TTM) | 239.00K | |||
| Net Change in Cash (TTM) | -592.20K | |||
| Levered Free Cash Flow (TTM) | -357.30K | |||
| Cash from Operations (TTM) | -913.90K | |||
